French Observational Survey to Assess Hypoglycaemia in Insulin-treated Diabetic Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

4424 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-05-31

Study Completion Date

2012-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This non-interventional study is conducted in Europe. The study is both retrospective and prospective.

The purpose of the study is to assess the frequency of hypoglycaemia (low blood glucose) in insulin-treated patients with type 1 and type 2 diabetes.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluating the True Magnitude of HYPOglycemic Events After THE Initiation of Sulfonylurea

NCT02485132

Type 2 Diabetes

TERMINATED

A Trial Comparing the Efficacy of Insulin Degludec With Insulin Glargine on Glycaemic Control Using Continuous Glucose Monitoring in Patients With Type 1 Diabetes

NCT01569841

Diabetes Diabetes Mellitus, Type 1

COMPLETED PHASE3

Intensive Insulin Glulisine Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Basal Insulin and Oral Glucose-lowering Drugs

NCT01203111

Diabetes Mellitus, Type 2

COMPLETED PHASE4

Observational Study to Evaluate Safety and Efficacy of Insulin Therapy in Type 2 Diabetes Mellitus Subjects Failing on Oral Anti-diabetic Agents

NCT00715780

Diabetes Diabetes Mellitus, Type 2

COMPLETED

Insulin Degludec and Symptomatic Nocturnal Hypoglycaemia

NCT02192450

Type 1 Diabetes Mellitus Nocturnal Hypoglycemia Recurrent Severe Hypoglycaemia

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

ECOLOGIC_OR_COMMUNITY

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with diabetes (type 1 and 2)

insulin

Intervention Type DRUG

Patients will be asked to complete 2 self-assessment questionnaires

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

insulin

Patients will be asked to complete 2 self-assessment questionnaires

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with Type 1 or Type 2 Diabetes Mellitus
* Patients treated by insulin for at least 12 months
* Patients able to perform capillary self-monitoring plasma glucose (SMPG) measurements
* Patients able to complete the questionnaires
* Patients who have accepted to participate to the survey (signature of an information notice)

Exclusion Criteria

* Patients with Type 2 Diabetes Mellitus not treated with insulin
* Females who are currently pregnant or lactating or who were pregnant during the previous year

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No